Becca Carlson

Becca Carlson joined Flagship Pioneering in 2024 as an Associate. At Flagship, Becca is part of a venture creation team that originates and develops breakthrough biotechnology companies.

Before joining Flagship, Becca was a Scientist at Digital Biology, a precision measurement startup. She completed her graduate research at the Broad Institute supported by a Hertz Fellowship and an NSF Graduate Research Fellowship. During her studies, Becca helped develop novel approaches to study innate immune signaling and host-pathogen interactions using imaging, functional genomics, and machine learning. In a co-first author paper, she discovered a novel function for the immune regulator STING as a proton channel, and her work has also revealed novel regulators of IRF3 signaling, Ebola virus replication, and STING localization. She was also a Hertz Fellow in Global Health and Development at the Bill & Melinda Gates Foundation in 2017.

Becca’s work has resulted in multiple patents and publications, including articles in Science, Cell, and PNAS, and invited talks at national and international conferences.

She received her Ph.D. in 2023 from the Harvard-MIT Health Sciences and Technology Department, working at the Broad Institute with Dr. Paul Blainey and Dr. Nir Hacohen. She also holds a B.S. in Chemical Engineering from Michigan State University.